Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...

In the face of rising avian influenza cases, the need for education and awareness on the topic grows. That's why dvm360 ...

Over the past week, both Hungary and Poland have reported increased outbreaks of highly pathogenic avian influenza affecting ...

The team tested the device using aerosolized inactivated viruses to evaluate the performance of the sensor unit. The machine sampled the air continuously, providing a readout every 5 min, and ...

Cases of highly pathogenic avian influenza, also known as bird flu, are rising across multiple areas of the UK, with new ...

One year ago, the first bird flu infection in a human in the United States was reported in a Texas dairy worker. There have ...

We cannot predict the finer details of a particular outbreak or a particular storm, but we can often identify when these ...

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil – (March 03, 2025) Traws Pharma, Inc. today announced positive topline results from ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Since 1959 the avian flu virus H5N1 has been popping up around the globe. Now scientists believe it could spark the next ...

The warning from the U.N.’s Food and Agriculture Organization came on March 17, the same day the a new U.S. outbreak of ...